CAPA In-vitro Oocyte Maturation (CUHK Medical Centre Limited)

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

June 30, 2035

Study Completion Date

July 1, 2036

Conditions
Infertility, Female
Interventions
OTHER

CAPA-IVM

In CAPA-IVM, the oocyte is treated and matured outside the woman's body, while in classical IVF, the patient is treated. As a consequence, patients undergoing CAPA-IVM are not confronted with the typical risks and burden of systemic ovarian stimulation.

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT07083427 - CAPA In-vitro Oocyte Maturation (CUHK Medical Centre Limited) | Biotech Hunter | Biotech Hunter